Nanotechnology
Researchers at Changzhou University have developed a innovative drug delivery system using nanoparticles that targets breast cancer cells while minimizing side effects. By leveraging microfluidics and functionalization with an anticancer peptide, the team created uniform nanoparticles capable of delivering curcumin to tumors with enhanced bioavailability and improved therapeutic efficacy. Key
Nanotechnology
A team of researchers at Manipal University has made a significant breakthrough in the development of nanocarriers for cancer therapy. They have synthesized and evaluated polymer-functionalized molybdenum disulfide (MoS) nanoplatforms with distinct morphologies, including three-dimensional (3D) nanoflowers and two-dimensional (2D) nanorods. The researchers' innovative approach has led to the
Nanotechnology
A team of researchers from China Agricultural University has made a significant discovery in the field of liver cancer treatment. By engineering nanoparticles that respond to hypoxia, the team was able to deliver chemotherapy drugs selectively to cancer cells, minimizing harm to healthy cells. The nanoparticles, called NI-HA-BMs-DOX, were tested
Nanotechnology
Researchers from the University of Tartu have made a significant breakthrough in cancer treatment by developing smart nanoparticles that can target tumors with precision and effectiveness. According to a recent study, these nanoparticles have the potential to revolutionize cancer treatment by achieving a selective and efficient tumor accumulation, reducing off-target
Nanotechnology
Scientists at the First Hospital of China Medical University have made a breakthrough in developing convenient and painless oral formulations of insulin. The research, published in the International Journal of Biological Macromolecules, highlights the challenges of oral insulin delivery and discusses the potential of mesoporous silica nanoparticles (MSNs) as drug
Nanotechnology
Researchers at the ISF College of Pharmacy in Punjab, India have been developing solid lipid nanoparticles as a novel drug delivery system. According to a recent study, these nanoparticles have attracted significant interest due to their innovative and adaptable properties. The delivery strategy offers numerous benefits over standard colloidal carriers,
Nanotechnology
Researchers from Jinzhou Medical University have developed a non-invasive transdermal delivery system using biomimetic shikonin nanoparticles to treat psoriasis. The system, known as FPB-CCNCD, shows significant enhancement in transdermal permeability, sustained release, and targeting of keratinocytes. In vitro experiments demonstrated the system's ability to promote keratinocyte apoptosis and
Nanotechnology
Researchers from Arizona State University have made significant progress in developing a new targeted cancer therapy using MUC1 aptamer-functionalized chitosan nanoparticles. This innovative approach aims to overcome multidrug resistance (MDR) in various cancer models by enhancing therapeutic efficacy and inducing synergistic effects. The study, published in the International Journal of
Nanotechnology
Researchers from the University of Helsinki have made a significant discovery in the field of nanotechnology, specifically in the development of DNA origami nanocarriers for drug delivery. These nanocarriers, which are designed to deliver doxorubicin, a cancer-fighting medication, have shown promising results in preliminary studies. However, the interaction between doxorubicin
Nanotechnology
New research in the field of nanotechnology has shed light on the potential of solid lipid nanoparticles (SLNs) as innovative drug delivery systems for ocular applications. A systematic review, conducted by researchers at the University Institute of Pharmaceutical Sciences, has evaluated the ability of SLNs to improve bioavailability, sustain drug
Nanotechnology
Researchers from Amity University in Uttar Pradesh, India, have made significant strides in the development of protein-based nanoparticles for pulmonary drug delivery. These nanoparticles possess unique properties, such as biocompatibility, biodegradability, high drug loading capacity, and tunable release profiles, making them ideal for targeted delivery and stimulus-responsive drug release. Despite
Nanotechnology
Researchers at the University of Tsukuba have developed an innovative explainable model, TransMA, which predicts the transfection efficiency of ionizable lipid nanoparticles (LNPs) in mRNA delivery. The model, presented in a recent study, showcases state-of-the-art performance in predicting transfection efficiency using the scaffold and cliff data splitting methods on the
